Orbism

orbismedicines.com

Orbis Medicines is a pioneering company focused on oral macrocycle drug discovery, utilizing its innovative n Gen platform to create and test a diverse range of macrocyclic compounds. The company aims to provide oral alternatives to existing biologic drugs, enhancing patient access to effective treatments. With a robust pipeline targeting both intra- and extracellular therapeutic areas, Orbis is positioned to make significant contributions to medicine. Their systematic approach to macrocycle design, combined with advanced data analytics and machine learning, allows for rapid development and testing of drug candidates, potentially accelerating the drug discovery process and reducing risks associated with development.